FDA Warns Ayurvedic UMA Oils Brand For Claims Slip-Ups
This article was originally published in The Rose Sheet
UMA Oils must lose claims on its skin- and hair-care products regarding acne and eczema treatment, among others, if it intends to continue marketing them as cosmetics, FDA says in a July warning letter. The company touts its offerings as based on ancient Ayurvedic principles and five generations of family expertise.
You may also be interested in...
The agency highlights claims for nine Be Natural Organics products – including statements about collagen production, cellular regeneration, hyperpigmentation reduction and eczema and acne treatment – in its recent warning letter to the company.
Blissoma Holistic Skincare and Apothecary draws an FDA warning for verboten claims on its Flawless Equalizing Anti-Blemish Oil Serum and Lavish Loving Recovery Beta-Glucan Mask, among other offerings.
Plaintiffs against the prestige, “clinical” skin-care company are targeting anti-aging claims on its Rose Stem Cell Bio-Repair line and statements about hyaluronic acid’s ultra-moisturizing capabilities, used to market its Water Drench range. PTR faces false advertising class actions in California and New York federal courts, and the former case appears to be headed for trial.